OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A New Chalcone Derivative C49 Reverses Doxorubicin Resistance in MCF-7/DOX Cells by Inhibiting P-Glycoprotein Expression
Ting Wang, Jingjing Dong, Yuan Xu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 13
Ting Wang, Jingjing Dong, Yuan Xu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 13
Showing 13 citing articles:
Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression
Milad Ashrafizadeh, Sepideh Mirzaei, Mohammad Gholami, et al.
Carbohydrate Polymers (2021) Vol. 272, pp. 118491-118491
Open Access | Times Cited: 130
Milad Ashrafizadeh, Sepideh Mirzaei, Mohammad Gholami, et al.
Carbohydrate Polymers (2021) Vol. 272, pp. 118491-118491
Open Access | Times Cited: 130
Chalcones and Gastrointestinal Cancers: Experimental Evidence
Radka Michalková, Martin Kello, Martina Čižmáriková, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5964-5964
Open Access | Times Cited: 16
Radka Michalková, Martin Kello, Martina Čižmáriková, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5964-5964
Open Access | Times Cited: 16
Editorial: Chemo-Radiation-Resistance in Cancer Therapy
Xiaoping Lin, Kong De, Zhe‐Sheng Chen
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 18
Xiaoping Lin, Kong De, Zhe‐Sheng Chen
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 18
Recent Progresses in Chalcone Derivatives as Potential Anticancer Agents
Jiahui Yang, Jianmei Lv, Shuxian Cheng, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 11, pp. 1265-1283
Closed Access | Times Cited: 10
Jiahui Yang, Jianmei Lv, Shuxian Cheng, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 11, pp. 1265-1283
Closed Access | Times Cited: 10
Hypophyllanthin and Phyllanthin from Phyllanthus niruri Synergize Doxorubicin Anticancer Properties against Resistant Breast Cancer Cells
Ola E. Abdel-Sattar, Rasha M. Allam, Ahmed M. Al‐Abd, et al.
ACS Omega (2023) Vol. 8, Iss. 31, pp. 28563-28576
Open Access | Times Cited: 9
Ola E. Abdel-Sattar, Rasha M. Allam, Ahmed M. Al‐Abd, et al.
ACS Omega (2023) Vol. 8, Iss. 31, pp. 28563-28576
Open Access | Times Cited: 9
Imperatorin-Loaded RH60/mPEG–PLLA Micelles for Reversing Tamoxifen Resistance in Breast Cancer
Qiuxiang Li, Guowei Zhao, Fengling Wu, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 2, pp. 1625-1635
Closed Access | Times Cited: 2
Qiuxiang Li, Guowei Zhao, Fengling Wu, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 2, pp. 1625-1635
Closed Access | Times Cited: 2
Exosomes derived from MDR cells induce cetuximab resistance in CRC via PI3K/AKT signaling‑mediated Sox2 and PD‑L1 expression
Zhenzhen Wei, Ziyuan Wang, Qiong Chai, et al.
Experimental and Therapeutic Medicine (2023) Vol. 25, Iss. 2
Open Access | Times Cited: 7
Zhenzhen Wei, Ziyuan Wang, Qiong Chai, et al.
Experimental and Therapeutic Medicine (2023) Vol. 25, Iss. 2
Open Access | Times Cited: 7
Non-self glycan structures as possible modulators of cancer progression: would polysaccharides from Cryptococcus spp. impact this phenomenon?
Israel Diniz-Lima, Leonardo Marques da Fonseca, Jhenifer Santos dos Reis, et al.
Brazilian Journal of Microbiology (2023) Vol. 54, Iss. 2, pp. 907-919
Closed Access | Times Cited: 3
Israel Diniz-Lima, Leonardo Marques da Fonseca, Jhenifer Santos dos Reis, et al.
Brazilian Journal of Microbiology (2023) Vol. 54, Iss. 2, pp. 907-919
Closed Access | Times Cited: 3
ABCB1 limits the cytotoxic activity of TAK-243, an inhibitor of the ubiquitin-activating enzyme UBA1
Zhuo‐Xun Wu, Yuqi Yang, Zi‐Ning Lei, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 6
Zhuo‐Xun Wu, Yuqi Yang, Zi‐Ning Lei, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 6
Medicinal Plants as A Potential Resource for The Discovery of Novel Structures Towards Cancer Drug Resistance Treatment
Hien Minh Nguyen, Thi Yen Nhi Nguyen, Nguyen Thien Han Le, et al.
Heliyon (2024) Vol. 10, Iss. 20, pp. e39229-e39229
Open Access
Hien Minh Nguyen, Thi Yen Nhi Nguyen, Nguyen Thien Han Le, et al.
Heliyon (2024) Vol. 10, Iss. 20, pp. e39229-e39229
Open Access
Enoxaparin Protects C6 Glioma Cells from Glutamate-Induced Cytotoxicity by Reducing Oxidative Stress and Apoptosis
Fatih Yulak, Zıad Joha, Ayşegül ÖZTÜRK, et al.
Molecular Neurobiology (2024)
Closed Access
Fatih Yulak, Zıad Joha, Ayşegül ÖZTÜRK, et al.
Molecular Neurobiology (2024)
Closed Access
Photoreactive Cytosine-Functionalized Self-Assembled Micelles with Enhanced Cellular Uptake Capability for Efficient Cancer Chemotherapy
Abere Habtamu Manayia, Fasih Bintang Ilhami, Ai‐Wei Lee, et al.
Biomacromolecules (2021) Vol. 22, Iss. 12, pp. 5307-5318
Closed Access | Times Cited: 3
Abere Habtamu Manayia, Fasih Bintang Ilhami, Ai‐Wei Lee, et al.
Biomacromolecules (2021) Vol. 22, Iss. 12, pp. 5307-5318
Closed Access | Times Cited: 3
Impact of Doxorubicin on Cell-Substrate Topology
Andreas Krecsir, Verena Richter, Michael Wagner, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6277-6277
Open Access | Times Cited: 2
Andreas Krecsir, Verena Richter, Michael Wagner, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6277-6277
Open Access | Times Cited: 2
